So how do these analysts compare to the consensus for NVDA stock? They do a good job representing analysts’ opinions. It’s also sticking to its $350 price target for the graphics card company.ħ Healthcare Stocks to Buy for the Long Term Cowen closes us out with its reiterated “outperform” rating for NVDA stock last week.His price target is a bit higher at $400 per share, which is a potential 56% gain for the company. Credit Suisse Group analyst John Pitzer is next with a reiterated “buy” rating for NVDA on Friday.For the record, that represents a potential 36.5% upside for the shares. It also continues to hold a $350 price prediction for the stock. Citigroup starts us off with the firm reiterating its “buy” rating for NVDA shares yesterday.That could be inspiring you to pick up some shares of the tech company’s stock, and who could blame you? But before you do that, let’s take a quick look at what some analysts have to say about investing in NVDA stock right now! Is NVDA Stock a Buy?
0 kommentar(er)
